Trinity Biotech Plc (TRIB)
0.688
-0.02
(-3.08%)
USD |
NASDAQ |
Jan 16, 16:00
0.6999
+0.01
(+1.73%)
After-Hours: 20:00
Trinity Biotech Total Assets (Quarterly): 103.71M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amarin Corp. Plc | 659.81M |
| DBV Technologies SA | 110.50M |
| Ascendis Pharma A/S | 1.357B |
| Cellectis SA | 343.04M |
| Akari Therapeutics Plc | 45.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 158.43M |
| Shareholders Equity (Quarterly) | -54.72M |
| Debt to Equity Ratio | -2.142 |
| Current Ratio | 1.030 |
| Net Debt Paydown Yield | -24.64% |